Metraipolis › archive › dc_9d72136fafe6

Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in… — Europe PMC PMID:41026784

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41026784
DOI
10.1371/journal.pone.0333581
License (as archived)
solo-consultazione
Archived
2026-11-09T17:01:26.705Z
SHA-256 of the archived text
1620da630a39cda0899b27125f703ccf5a5b9f0e1fc34b81c462810dc73407bd
Stable URL of this page
https://metraipolis.com/documento/dc_9d72136fafe6

How to cite

Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in… — Europe PMC PMID:41026784 — Europe PMC (en), https://europepmc.org/article/MED/41026784 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9d72136fafe6 (Metraipolis archive dc_9d72136fafe6, sha256 1620da630a39cda0899b27125f703ccf5a5b9f0e1fc34b81c462810dc73407bd)
BibTeX
@misc{dc9d72136fafe6,
  title = {Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in… — Europe PMC PMID:41026784},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41026784},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9d72136fafe6; sha256 1620da630a39cda0899b27125f703ccf5a5b9f0e1fc34b81c462810dc73407bd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41026784. Agents can read the archived copy with the MCP tool read_document.